National Cancer Center, National Research And Development Agency
Chuo City, Tokyo
Company facts
- Self-certified in SAM.gov
- Entity structure
- Country - Foreign Government
- SAM.gov registration date
- Physical address
- 5-chōme-1-1 Tsukiji, Chuo City, Tokyo 104-0045, Japan
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $15,075 |
| FY2025 | $24,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $15,075 |
Contract awards
Similar vendors
About the company
National Cancer Center, National Research And Development Agency, a foreign government research institution headquartered in Tokyo, Japan, has received three small purchase orders from the National Cancer Institute (NCI) totaling $39 thousand since May 2025, operating exclusively as a prime contractor on laboratory testing and data preparation work for U.S. federal cancer research. The vendor is not eligible for federal contracting set-asides and competes on full-and-open basis.
The National Cancer Center serves a single federal customer: the National Cancer Institute accounts for 100% of awards and 100% of combined potential value. All three awards are firm fixed-price purchase orders issued by NCI between May 2025 and May 2026. The first order (May 16, 2025, $24 thousand ceiling) procured laboratory testing services—whole-genome scans and phenotype data preparation on 1,000 never-smoking female lung adenocarcinoma cases conducted in Japan, with completion date September 15, 2025. The second award (June 25, 2025, $24 thousand ceiling) covered additional laboratory testing services, ultimately completing December 9, 2025. The most recent order (May 14, 2026, $15,075 ceiling) replaces a prior PO to correct the vendor's UEI number, with performance in Bethesda, Maryland and completion date May 13, 2027.
Activity is minimal and intermittent—two awards in 2025 and one in 2026—with one award (combined potential value $15 thousand) reaching ultimate completion within the next twenty-four months. Combined dollars obligated across all awards match combined potential value at $39 thousand, indicating full funding or commitment. The vendor's work falls under NAICS testing laboratories and services and specialty hospital categories, with task descriptions spanning reference laboratory testing and research operations support. No subcontract footprint is present in the source data.
Quick answers
Is National Cancer Center, National Research And Development Agency registered in SAM.gov?
Yes. National Cancer Center, National Research And Development Agency's SAM.gov registration is active through March 27, 2027.
What is National Cancer Center, National Research And Development Agency's CAGE code?
National Cancer Center, National Research And Development Agency's CAGE code is JSH62, and its Unique Entity ID (UEI) is KFUZACARW5N3.
How much has National Cancer Center, National Research And Development Agency received in federal contracts?
Federal contracts obligated $24,000 to National Cancer Center, National Research And Development Agency in fiscal year 2025 and $39,075 in fiscal years 2023 through 2027.
What is National Cancer Center, National Research And Development Agency's most recent federal award?
National Cancer Center, National Research And Development Agency's most recent federal contract award is This order replaces PO 75N91021P00879 to correct the UEI number (75N98026P00537), from Office of Logisitics and Acquisition Operations (NIH), on May 14, 2026.
On GovTribe
See National Cancer Center, National Research And Development Agency's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors